Structure-based discovery of CFTR potentiators and inhibitors
Cell · 2024
DOI: 10.1016/j.cell.2024.04.046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024. Verfasst von Fangyu Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065, USA; Department of Pharmaceutical Chemistry, Universit…. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Molecular Docking Simulation, Cystic Fibrosis, Aminophenols. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Genentech, Howard Hughes Medical Institute.
Abstract (Originalsprache)
The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, whereas its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available. However, the only potentiator, ivacaftor, has suboptimal pharmacokinetics and inhibitors have yet to be clinically developed. Here, we combine molecular docking, electrophysiology, cryo-EM, and medicinal chemistry to identify CFTR modulators. We docked ∼155 million molecules into the potentiator site on CFTR, synthesized 53 test ligands, and used structure-based optimization to identify candidate modulators. This approach uncovered mid-nanomolar potentiators, as well as inhibitors, that bind to the same allosteric site. These molecules represent potential leads for the development of more effective drugs for cystic fibrosis and secretory diarrhea, demonstrating the feasibility of large-scale docking for ion channel drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065, USA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143, USA.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143, USA.
- Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065, USA.
- Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander University Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, D-91058 Erlangen, Germany.
- Enamine Ltd., Chervonotkatska Street 78, 02094 Kyïv, Ukraine; V.P. Kukhar Institute of Bioorganic Chemistry & Petrochemistry, National Academy of Sciences of Ukraine, Murmanska Street 1, 02660 Kyïv, Ukraine.
- Chemspace, Chervonotkatska Street 85, 02094 Kyïv, Ukraine; Taras Shevchenko National University of Kyïv, Volodymyrska Street 60, 01601 Kyïv, Ukraine.
Förderung
- NIGMS NIH HHS
- Genentech
- Howard Hughes Medical Institute
- Deutsche Forschungsgemeinschaft
- NIH
Zitieren
APA
Liu, F., Kaplan, A. L., Levring, J., Einsiedel, J., Tiedt, S., Distler, K., Omattage, N. S., Kondratov, I. S., Moroz, Y. S., Pietz, H. L., Irwin, J. J., Gmeiner, P., Shoichet, B. K., & Chen, J. (2024). Structure-based discovery of CFTR potentiators and inhibitors. Cell. https://doi.org/10.1016/j.cell.2024.04.046
Vancouver
Liu F, Kaplan AL, Levring J, Einsiedel J, Tiedt S, Distler K, et al. Structure-based discovery of CFTR potentiators and inhibitors. Cell. 2024. doi:10.1016/j.cell.2024.04.046
BibTeX
@article{Liu2024,
author = {Liu, Fangyu and Kaplan, Anat Levit and Levring, Jesper and Einsiedel, Jürgen and Tiedt, Stephanie and Distler, Katharina and Omattage, Natalie S and Kondratov, Ivan S and Moroz, Yurii S and Pietz, Harlan L and Irwin, John J and Gmeiner, Peter and Shoichet, Brian K and Chen, Jue},
title = {Structure-based discovery of CFTR potentiators and inhibitors},
journal = {Cell},
year = {2024},
doi = {10.1016/j.cell.2024.04.046}
}
EUVIMED